Yarema Kristin 4
4 · Atara Biotherapeutics, Inc. · Filed Jun 15, 2021
Insider Transaction Report
Form 4
Yarema Kristin
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2021-06-11$14.50/sh+2,021$29,305→ 93,549 total - Purchase
Common Stock
2021-06-14$14.48/sh+3,500$50,680→ 97,049 total - Purchase
Common Stock
2021-06-14$14.58/sh+28,833$420,385→ 125,882 total
Footnotes (1)
- [F1]The reporting person's sale of ATRA common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 761 shares, with the reporting person's sale of 761 shares of ATRA common stock at a weighted average price of $14.55 per share on May 18, 2021. The reporting person has agreed to pay to ATRA $53.27, representing the full amount of the profit realized in connection with the short-swing transaction.